Chemring Regulatory News (CHG)

FOR IMMEDIATE RELEASE 1 JULY 2026

CHEMRING GROUP PLC ("Chemring", the "Group" or the "Company")

JBTDS FRP AWARD

Chemring is pleased to announce that its US subsidiary, Chemring Sensors & Electronic Systems ("CSES"), has been awarded a sole source Indefinite Delivery / Indefinite Quantity ("IDIQ") Full Rate Production ("FRP") contract for the Joint Biological Tactical Detection System ("JBTDS") Programme of Record. This three-year IDIQ, which was awarded by the Capability Program Executive for Chemical, Biological, Radiological and Nuclear Defense, has a current contract ceiling value of $48.8m and an estimated completion date of June 2029.

An initial production contract was also received with a value of $36.3m and a period of performance through to March 2028. Work under this contract will be performed at CSES's site in Charlotte, North Carolina.

The JBTDS system is an advanced sensor system that rapidly detects and identifies airborne biological warfare agents, and this award follows a period of successful field testing and acceptance trials with the US military.

Michael Ord, Group Chief Executive of Chemring, commented:

"For over two decades CSES has delivered mission-critical detection capabilities that protect the warfighter against complex and evolving biological threats, and we are delighted to receive this sole source contract in support of such a critical programme.

"This FRP award, which is the culmination of years of research and development, sits alongside our sole source position on the Enhanced Maritime Biological Detector programme for the US Navy, and positions Chemring as the market leader in the field of biological warfare agent detection."

-ENDS-

For further information:

Rupert Pittman Group Director of Corporate Affairs, 01794 463401

Chemring Group PLC

James McFarlane MHP Group 07584 142665

Ollie Hoare 07817 458804

Cautionary statement

This announcement contains forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Chemring's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements. There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are: increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects. Chemring undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

Notes to editors

· Chemring is a FTSE-250 listed global business that specialises in the manufacture of high technology products and the provision of services to the defence, security and aerospace markets

· Employing approximately 2,700 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries

· Chemring is organised under two strategic product segments: Sensors & Information and Countermeasures & Energetics

· Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, missions and information against constantly changing threats

· Operating in niche markets and with strong investment in research and development ("R&D"), Chemring has the agility to rapidly react to urgent customer needs

www.chemring.com